An oral apolipoprotein A-I mimetic peptide, D-4F, converts monkey HDL to anti-inflammatory

被引：0
|
作者：
Bachini, EA [1 ]
Hama, S [1 ]
Yu, N [1 ]
Chyu, C [1 ]
Hough, G [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1055 / A1055
页数：1
相关论文
共 50 条
  • [1] Oral administration of the apolipoprotein A-1 mimetic peptide D-4F in humans with CHD improves HDL anti-inflammatory function after a single dose
    Bloedon, LeAnne T.
    Dunbar, Richard L.
    Duffy, Danielle
    Pinell-Salles, Paula
    Navab, Mohamad
    Fogelman, Alan
    Rader, Daniel J.
    CIRCULATION, 2006, 114 (18) : 288 - 288
  • [2] Daily oral administration of the apolipoprotein A-I mimetic peptide D-4F in patients with CHD or equivalent risk improves high-density lipoprotein anti-inflammatory function
    Dunbar, Richard L.
    Bloedon, LeAnne T.
    Duffy, Danielle
    Norris, Robert B.
    Movva, Rajesh
    Navab, Mohamed
    Fogelman, Alan M.
    Rader, Daniel J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 366A - 366A
  • [3] D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes
    Van Lenten, BJ
    Wagner, AC
    Navab, M
    Anantharamaiah, GM
    Hui, EKW
    Nayak, DP
    Fogelman, AM
    CIRCULATION, 2004, 110 (20) : 3252 - 3258
  • [4] Oral administration of the apoA-I mimetic peptide D-4F causes the rapid formation and clearance of small anti-inflammatory HDL-like particles in mice
    Navab, M
    Hama, S
    Hough, G
    Reddy, S
    Anantharamaiah, M
    Fogelman, A
    CIRCULATION, 2003, 108 (17) : 232 - 232
  • [5] Oral administration of Apolipoprotein A-I mimetic peptide D-4F reduces lipid accumulation in murine Bruch's membrane (BrM)
    Rudolf, Martin
    Mohi, Armin
    Aherrahrou, Zouhair
    Grisanti, Salvatore
    Miura, Yoko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [6] Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide
    Van Lenten, BJ
    Wagner, AC
    Anantharamaiah, GM
    Garber, DW
    Fishbein, MC
    Adhikary, L
    Nayak, DP
    Hama, S
    Navab, M
    Fogelman, AM
    CIRCULATION, 2002, 106 (09) : 1127 - 1132
  • [7] D-4F, an apolipoprotein A-I mimetic peptide, prevents endothelial dysfunction induced by myeloperoxidase-derived hypochlorous acid
    Zhang, Zhenghao
    Datta, Geeta
    Mishra, Vinod K.
    Anantharamaiah, G. M.
    White, C. Roger
    FASEB JOURNAL, 2007, 21 (06): : A748 - A748
  • [8] Administration of an oral apolipoprotein A-I mimetic peptide, D-4F, in monkeys, reduces LDL lipid hydroperoxides resulting in decreased monocyte migration by LDL oxidation
    Yu, N
    Chyu, C
    Bachini, E
    Hama, S
    Hough, G
    FASEB JOURNAL, 2005, 19 (05): : A1054 - A1054
  • [9] Anti-inflammatory effects of a high-density lipoprotein mimetic peptide, D-4F, on arterial walls.
    Huang, W. A.
    Gharavi, N. M.
    Mouillesseaux, K. P.
    Berliner, L. A.
    Watson, A. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S84 - S84
  • [10] Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial
    Dunbar, Richard L.
    Movva, Rajesh
    Bloedon, LeAnne T.
    Duffy, Danielle
    Norris, Robert B.
    Navab, Mohamad
    Fogelman, Alan M.
    Rader, Daniel J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2017, 10 (06): : 455 - 469
12345